ProQR Therapeutics
PRQR
25 hedge funds and large institutions have $58M invested in ProQR Therapeutics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 3 closing their positions.
31% more capital invested
Capital invested by funds: $44.3M → $58M (+$13.7M)
4% less funds holding
Funds holding: 26 → 25 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$569K |
| 2 |
M&T Bank
Buffalo,
New York
|
+$68.3K |
| 3 |
JP Morgan Chase
New York
|
+$33.1K |
| 4 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$30.6K |
| 5 |
Morgan Stanley
New York
|
+$19.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$2.06M |
| 2 |
Jennison Associates
New York
|
-$305K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$281K |
| 4 |
Millennium Management
New York
|
-$212K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$74.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Renaissance Technologies
New York
| – | -$63K | -13,000 | Closed |
|
|
FO
27
FT Options
Chicago,
Illinois
| – | -$61K | -12,523 | Closed |
|
28
UBS Group
Zurich,
Switzerland
| – | -$13K | -2,627 | Closed |
|
PRQR Hedge Fund Activity: Q3 2016 in Review
25 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q3 2016, worth a combined $58M — up 31% from $44.3M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PRQR and 2 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 6 added.
The largest buyer was Highland Capital Management (Texas), adding an estimated $569K. The largest seller was Baker Bros. Advisors, cutting an estimated $2.06M.
- 25 institutional investors held ProQR Therapeutics (PRQR) as of Q3 2016, down from 26 in Q2 2016.
- Funds reported $58M of ProQR Therapeutics stock for Q3 2016, up 31% quarter-over-quarter.
- 2 funds opened new ProQR Therapeutics positions in Q3 2016 and 3 closed out, a net change of -1 holder.
- The largest ProQR Therapeutics buyer in Q3 2016 was Highland Capital Management (Texas), an estimated $569K added.
- The largest ProQR Therapeutics seller in Q3 2016 was Baker Bros. Advisors, an estimated $2.06M sold.
Based on aggregated 13F filings for Q3 2016.